← Leaderboards
Yigang Wang
University Of Cincinnati
$11,973,905
Attributed
$16,034,516
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,034,516 · 9
By mechanism
R01$15,561,551 · 8
R56$472,965 · 1
Top collaborators
- Muhammad Ashraf5 shared
- W. Sean Davidson4 shared
- Jialiang Liang4 shared
- Wei Huang2 shared
Most similar at University Of Cincinnati
Same institution · by research overlap
- T Douglas Mast$4,815,417
- W. Sean Davidson$21,578,443
- Muhammad Ashraf$27,715,813
- Wei Huang$1,901,262
- Jialiang Liang$1,434,328
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacMyocardiumInfarctionStem CellsMyocardial InfarctionMediatingRepairedHeart FunctionCardiac MyocytesEngraftmentNatural RegenerationMyocardial IschemiaOverexpressionCellsCardiovascular SystemIn VivoHeartHeart FailureCicatrixTissuesSafetyBaseDesignGenetic
Grant awards (33)
A novel strategy for heart failure therapeutics$534,928
R01 · FY2025 · HL · contact PI
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction$564,836
R01 · FY2024 · HL · contact PI
A novel strategy for heart failure therapeutics$542,133
R01 · FY2024 · HL · contact PI
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction$577,574
R01 · FY2023 · HL · contact PI
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction$547,786
R01 · FY2022 · HL · contact PI
IGF-2R is a new therapeutic target for cardiac ischemia-reperfusion injury$414,732
R01 · FY2022 · HL · contact PI
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction$692,459
R01 · FY2021 · HL · contact PI
IGF-2R is a new therapeutic target for cardiac ischemia-reperfusion injury$411,747
R01 · FY2021 · HL · contact PI
Autologous Cardiomyocytes from Masseter Muscles to Repair Myocardial Infarction (MI)$446,160
R01 · FY2020 · HL · contact PI
IGF-2R is a new therapeutic target for cardiac ischemia-reperfusion injury$411,747
R01 · FY2020 · HL · contact PI
Autologous Cardiomyocytes from Masseter Muscles to Repair Myocardial Infarction (MI)$445,599
R01 · FY2019 · HL · contact PI
IGF-2R is a new therapeutic target for cardiac ischemia-reperfusion injury$411,432
R01 · FY2019 · HL · contact PI
Autologous Cardiomyocytes from Masseter Muscles to Repair Myocardial Infarction (MI)$451,048
R01 · FY2018 · HL · contact PI
Autologous Cardiomyocytes from Masseter Muscles to Repair Myocardial Infarction (MI)$449,807
R01 · FY2017 · HL · contact PI
Autologous Cardiomyocytes from Masseter Muscles to Repair Myocardial Infarction$472,965
R56 · FY2016 · HL · contact PI
iPS cells-derived progenitor cells for angiomyogenesis$714,954
R01 · FY2015 · HL · contact PI
Angiomyogenesis With Myoblast Derived iPS Cells$673,493
R01 · FY2015 · HL · contact PI
iPS cells-derived progenitor cells for angiomyogenesis$717,972
R01 · FY2014 · HL · contact PI
Angiomyogenesis With Myoblast Derived iPS Cells$670,074
R01 · FY2014 · HL · contact PI
Angiomyogenesis With Myoblast Derived iPS Cells$650,930
R01 · FY2013 · HL · contact PI
iPS cells-derived progenitor cells for angiomyogenesis$586,010
R01 · FY2013 · HL · contact PI
Stem Cell Therapy$386,100
R01 · FY2012 · HL · contact PI
iPS cells-derived progenitor cells for angiomyogenesis$286,122
R01 · FY2012 · HL · contact PI
iPS cells-derived progenitor cells for angiomyogenesis$563,834
R01 · FY2011 · HL · contact PI
Stem Cell Therapy$390,000
R01 · FY2011 · HL · contact PI
Stem Cell Therapy$390,000
R01 · FY2010 · HL · contact PI
Stem Cell Therapy$390,000
R01 · FY2009 · HL · contact PI
Lineage Specific Stem Cell Mobilization for Heart Repair$363,864
R01 · FY2009 · HL · contact PI
Stem Cell Therapy$390,000
R01 · FY2008 · HL · contact PI
Lineage Specific Stem Cell Mobilization for Heart Repair$363,864
R01 · FY2008 · HL · contact PI
Lineage Specific Stem Cell Mobilization for Heart Repair$363,864
R01 · FY2007 · HL · contact PI
Lineage Specific Stem Cell Mobilization for Heart Repair$374,732
R01 · FY2006 · HL · contact PI
Lineage Specific Stem Cell Mobilization for Heart Repair$383,750
R01 · FY2005 · HL